Viewing Study NCT04194203


Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2026-01-01 @ 4:30 PM
Study NCT ID: NCT04194203
Status: COMPLETED
Last Update Posted: 2024-07-19
First Post: 2019-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151)
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module